AzTrials
AzTrials

HIV InfectionsNCT00393575

C2P Mobilization Intervention (Pilot)

A study testing Community Mobilization in people with HIV Infections, run by University of North Carolina, Chapel Hill at 15 sites in 2 countries.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Connect to Protect (C2P): Partnerships for Youth Prevention Interventions is a multi-site, three-phase project developed by the Adolescent Medicine Trials Network for HIV/AIDS Interventions (ATN). Read more about this study

Who is it for?
Any ageHealthy volunteers can take part
Conditions the study is for
HIV Infections
What is being tested?
Community Mobilization
Could I receive a placebo?
No, everyone receives an active treatment
How many people
15 participants
Where
15 sitesin 2 countries
Study dates
Jan 2006to Mar 2010
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Any age
  • All sexes
  • Healthy volunteers accepted
  • Child, Adult, Older adult

Who may be able to join

  • Community each ATN/C2P site is attempting to mobilize

Who cannot join

  • Non-ATN funded site

Trial locations and contacts

15 sites in 2 countries.

15 sites in 2 countries

United States14 sites
  • University of Maryland

    Baltimore, Maryland, 21201

  • Childrens' Hospital Boston

    Boston, Massachusetts, 02115

  • Stroger Hospital of Cook County

    Chicago, Illinois, 60612

  • Children's Diag. & Treatment Ctr.

    Fort Lauderdale, Florida, 33301

  • Children's Hospital of Los Angeles

    Los Angeles, California, 90054

  • University of Miami

    Miami, Florida, 33101

  • Tulane Medical Center

    New Orleans, Louisiana, 70112

  • Mount Sinai Medical Center

    New York, New York, 10128

  • The Children's Hosp. of Philadelphia

    Philadelphia, Pennsylvania, 19104

  • Univ of California at San Diego

    San Diego, California, 92093-0672

  • Univ of California at San Francisco

    San Francisco, California, 94143-0503

  • University of South Florida

    Tampa, Florida, 33606

  • Director, Adolescent AIDS Program

    The Bronx, New York, 10467-2490

  • Children's Hosp. National Med. Ctr.

    Washington D.C., District of Columbia, 20010

Other trials in United States

Puerto Rico1 site
  • University Pediatric Hospital

    San Juan, 00936-5067

Other trials in Puerto Rico

About this study

Official title: Connect To Protect® Partnerships for Youth Prevention Interventions: Phase III

Connect to Protect (C2P): Partnerships for Youth Prevention Interventions is a multi-site, three-phase project developed by the Adolescent Medicine Trials Network for HIV/AIDS Interventions (ATN). The overall goal of the project is to ultimately reduce HIV incidence and prevalence in youth 12-24 years old through a community mobilization intervention. This protocol (ATN 040) describes part one of Phase III. Part two of Phase III will be submitted as a separate protocol (ATN 041).

Read the detailed description

The objective of Phase III is to initiate and complete a community mobilization intervention aimed at ultimately reducing HIV incidence and prevalence among youth. The intervention will consist of guiding C2P coalitions through a strategic planning process that will result in the development and implementation of a local action plan. The action plan will focus on changing structural elements of the affected communities that are believed to be associated with youth HIV acquisition and transmission. Each coalition's plan will include: (1) identification of potential community structural changes and specific steps for how to effect such changes; and (2) the selection of a community-level Centers for Disease Control and Prevention (CDC)-endorsed HIV prevention program. These activities will be described in this document. Details related to the training, technical assistance, adaptation, and implementation of the selected CDC program will be subsequently submitted for IRB review as part two of Phase III (ATN 041).

The intervention consists of community mobilization activities that are expected to lead to structural change and the adaptation and delivery of a CDC-endorsed HIV-prevention program. ATN/C2P staff at each site, with training and technical assistance from a C2P National Coordinating Center, will engage in a strategic planning process with their coalition members that results in the development and implementation of a local action plan.

The evaluation of the intervention will be within and across ATN/C2P sites implementing this protocol. For assessing the overall efficacy of the community mobilization intervention, data will be collected and analyzed from:

  1. ATN/C2P site staff, in the form of systematic documentation of the community mobilization process and accomplishments (e.g., structural change achieved); and
  2. Local public health departments and other similar sources of epidemiological information, as was done for generating Phase I epidemiologic profiles.

Duration: 4 years.

Conditions
HIV Infections
Being tested
Community Mobilization
Keywords
HIV Prevention, HIV positive communities
Medical subject headings
HIV Infections

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Community MobilizationBehavioural

    The intervention will consist of guiding C2P coalitions through a strategic planning process that will result in the development and implementation of a local action plan. The action plan will focus on changing structural elements of the affected communities that are believed to be associated with youth HIV acquisition and transmission. Each coalition's plan will include: (1) identification of potential community structural changes and specific steps for how to effect such changes; and (2) the selection of a community-level Centers for Disease Control and Prevention (CDC)-endorsed HIV prevention program.

Study groups in NCT00393575
Study groupRoleWhat they receive
Community MobilizationExperimentalThe intervention population is defined as the community each site is attempting to mobilize.
Receives: Behavioral: Community Mobilization

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Increasing levels of community mobilization will be associated with increasing levels of structural change over four years, as measured by new or modified programs, policies, and practices, within and across intervention communities.

    Measured: Determined in analysis

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted30 Oct 2006 (estimated)
  2. Study startJan 2006
  3. Primary completionMar 2010
  4. Study completionMar 2010

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
15 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT00393575
Sponsor's protocol ID
ATN 040
Status last verified
Jul 2016
First submitted
28 Dec 2005
Last updated
28 Feb 2017
Results posted
No
Data monitoring committee
Yes

Questions about this trial

What is this clinical trial studying?

A study testing Community Mobilization in people with HIV Infections, run by University of North Carolina, Chapel Hill at 15 sites in 2 countries.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 28 Feb 2017. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 15 sites in United States, Puerto Rico. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Increasing levels of community mobilization will be associated with increasing levels of structural change over four years, as measured by new or modified programs, policies, and practices, within and across intervention communities. (time frame: Determined in analysis). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 28 Feb 2017.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in